Causaly
ID: 5373264
Seedtable Score
60
Startups
3
Funding Rounds
4
Investors
$78.2m
Money raised
Recent Funding Rounds
Overview
Causaly, a London-based company, shows significant potential at the intersection of artificial intelligence, biotechnology, and pharmaceuticals. Its SaaS platform accelerates biomedical research by replacing traditional, manual data analysis with advanced AI, streamlining processes and speeding up progress. This advantage is crucial in a field where time-to-discovery impacts patient outcomes and healthcare advancements. Supported by prominent investors, Causaly is well-positioned to meet the growing demand for innovative health tech solutions, making it a strong contender in biomedical research.
- Website: https://causaly.com
- Business model: b2b, saas
- Company size: 51 - 101 employees
- Headquarters: London, UK
- Founded: 2018
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (4)
Funding
Funding series
Funding Series Analysis
The company Causaly has raised a total of $78.2m in funding over 3 rounds.
Key Insights:
- Series B: $60m
- Series A: $17m
- Seed: $1.2m
Causaly Series A (2021, $17M)
$17m
Causaly Series B (2023, $60M)
$60m
Causaly Seed (2018, $1M)
$1.2m